---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-015182"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2025-02-19T23:59:59+00:00"
generated_at: "2026-05-26T10:34:09.874418+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma amends Series A warrant terms for certain holders

## Summary
- Increases change-of-control threshold from 50% to >50% in Fundamental Transaction definition.
- Revises expected volatility rate for Black Scholes Value calculation in warrant valuation.
- Removes Section 3(h) which adjusted exercise price on reverse stock split events.
- Series A Warrants originally issued Dec 29, 2024 as part of Class A and Class B Units.

## SEC filing metadata
- accession: 0001104659-25-015182
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2025-02-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465925015182/0001104659-25-015182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465925015182/tm257041d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-015182
- JSON: https://secwatch.observer/filing/0001104659-25-015182.json
- Plain text: https://secwatch.observer/filing/0001104659-25-015182.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.